<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00370799</url>
  </required_header>
  <id_info>
    <org_study_id>protocol 10</org_study_id>
    <nct_id>NCT00370799</nct_id>
  </id_info>
  <brief_title>Effectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity Pain</brief_title>
  <official_title>A Randomized, Prospective, Double-Blind Controlled Evaluation of the Effectiveness of Caudal Epidural Injections in Lumbar Disc Herniations, Spinal Stenosis, Discogenic Pain, and Post-Lumbar Laminectomy Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pain Management Center of Paducah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pain Management Center of Paducah</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate clinically significant improvements or lack thereof in the caudal epidural&#xD;
      patients with our without steroids.&#xD;
&#xD;
      To evaluate differences in outcomes in patients receiving steroids compared to those patients&#xD;
      randomized to the local anesthetic group who did not receive steroids.&#xD;
&#xD;
      To assess improvements among patients and compare steroid groups with each other and local&#xD;
      anesthetic group.&#xD;
&#xD;
      To evaluate and compare the adverse event profile in all patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with chronic low back pain of at least 6 months duration, non-responsive to&#xD;
      conservative management with NSAIDS, physical therapy or chiropractic treatment exercises.&#xD;
&#xD;
      A single-center, prospective, controlled, double blinded, randomized study of patients in 4&#xD;
      groups.&#xD;
&#xD;
        -  Group 1. local anesthetics only&#xD;
&#xD;
        -  Group 2. local anesthetic with 6mg of non-particulate Celestone&#xD;
&#xD;
        -  Group 3. local anesthetic with 6 mg of brand name Celestone&#xD;
&#xD;
        -  Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol&#xD;
&#xD;
      All patients will be unblinded in 12 months.&#xD;
&#xD;
      Non-responsive patients will be unblinded after 3 months and will be crossed over to a&#xD;
      different group&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate for differences between the patients in various groups in the physical function and pain at 1, 3, 6, and 12 months post treatment</measure>
    <time_frame>1,3,6,12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess adverse events in all four groups.</measure>
    <time_frame>1,3,6,12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>local anesthetic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 1. local anesthetics only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic with generic Celestone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 2. local anesthetic with 6mg of non-particulate Celestone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic with Celestone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 3. local anesthetic with 6 mg of brand nameCelestone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic with DepoMedrol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal epidural injection</intervention_name>
    <description>group 1: Caudal epidural injection local anesthetics only</description>
    <arm_group_label>local anesthetic</arm_group_label>
    <other_name>Group 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal Epidural Injection with generic Celestone</intervention_name>
    <description>Group 2. Caudal Epidural Injection local anesthetic with 6mg of non-particulate Celestone</description>
    <arm_group_label>Local anesthetic with generic Celestone</arm_group_label>
    <other_name>Group 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal Epidural Injection with Celestone</intervention_name>
    <description>Group 3. Caudal Epidural Injection with local anesthetic with 6 mg of brand name Celestone</description>
    <arm_group_label>Local anesthetic with Celestone</arm_group_label>
    <other_name>Group 3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal Epidural Injection with DepoMedrol</intervention_name>
    <description>Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol</description>
    <arm_group_label>Local anesthetic with DepoMedrol</arm_group_label>
    <other_name>Group 4</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years of age&#xD;
&#xD;
          -  History of chronic, function-limiting low back pain of at least 6 months duration&#xD;
&#xD;
          -  Able to give voluntary, written informed consent to participate,&#xD;
&#xD;
          -  Able to understand the investigation, cooperate with the procedures, and willing to&#xD;
             return for follow-up&#xD;
&#xD;
          -  No recent surgical procedures within last three months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cauda Equina symptoms and/or compressive radiculopathy&#xD;
&#xD;
          -  Narcotic use of no greater than 100mg/day hydrocodone, 60mg Methadone. or 100mg&#xD;
             morphine&#xD;
&#xD;
          -  Uncontrolled major Depression or uncontrolled psychiatric disorder&#xD;
&#xD;
          -  Uncontrolled or acute medical illnesses&#xD;
&#xD;
          -  Chronic severe conditions that could interfere with outcome assessments&#xD;
&#xD;
          -  Women who are pregnant or lactating&#xD;
&#xD;
          -  Subjects who have participated in a clinical study with an investigational product&#xD;
             within 30 days of enrollment&#xD;
&#xD;
          -  Patients with multiple complaints involving concomitant hip osteoarthritis&#xD;
&#xD;
          -  Inability to achieve proper positioning and inability to understand informed consent&#xD;
             and protocol&#xD;
&#xD;
          -  History of adverse reaction to local anesthetic or anti-inflammatory drugs and history&#xD;
             of gastrointestinal bleeding or ulcers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laxmaiah Manchikanti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ambulatory Surgery Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ambulatory Surgery Center</name>
      <address>
        <city>Paducah</city>
        <state>Kentucky</state>
        <zip>42001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <study_first_submitted>August 30, 2006</study_first_submitted>
  <study_first_submitted_qc>August 30, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2006</study_first_posted>
  <last_update_submitted>August 14, 2013</last_update_submitted>
  <last_update_submitted_qc>August 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pain Management Center of Paducah</investigator_affiliation>
    <investigator_full_name>Laxmaiah Manchikanti, MD</investigator_full_name>
    <investigator_title>Medical Director</investigator_title>
  </responsible_party>
  <keyword>Caudal Epidural injections</keyword>
  <keyword>lumbar disc herniation</keyword>
  <keyword>spinal stenosis</keyword>
  <keyword>discogenic pain</keyword>
  <keyword>post-lumbar laminectomy syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Methylprednisolone Acetate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

